Howard Hughes - HHC Stock Forecast, Price & News

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Howard Hughes in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" HHC shares.
View HHC analyst ratings or view top-rated stocks.

4 Wall Street analysts have issued 1 year target prices for Howard Hughes' stock. Their HHC share price forecasts range from $90.00 to $125.00. On average, they expect the company's stock price to reach $101.25 in the next year. This suggests a possible upside of 73.3% from the stock's current price.
View analysts price targets for HHC or view top-rated stocks among Wall Street analysts.

Howard Hughes' stock was trading at $101.78 on January 1st, 2022. Since then, HHC stock has decreased by 42.6% and is now trading at $58.41.
View the best growth stocks for 2022 here.

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 3rd 2022.
View our HHC earnings forecast.

The Howard Hughes Co. (NYSE:HHC) released its earnings results on Monday, May, 9th. The financial services provider reported $0.04 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.58) by $0.62. Howard Hughes had a trailing twelve-month return on equity of 3.93% and a net margin of 9.36%. During the same period last year, the firm posted ($0.55) earnings per share.

Howard Hughes declared that its Board of Directors has authorized a stock buyback plan on Tuesday, March 15th 2022, which permits the company to repurchase $250,000,000.00 in shares, according to EventVestor. This repurchase authorization permits the company to reacquire up to 4.7% of its stock through open market purchases. Stock repurchase plans are often an indication that the company's leadership believes its stock is undervalued.

Based on aggregate information from My MarketBeat watchlists, some companies that other Howard Hughes investors own include Gilead Sciences (GILD), NVIDIA (NVDA), Esperion Therapeutics (ESPR), Walt Disney (DIS), Carnival Co. & (CCL), AT&T (T), CVS Health (CVS), QUALCOMM (QCOM), Johnson & Johnson (JNJ) and Alibaba Group (BABA).

Howard Hughes trades on the New York Stock Exchange (NYSE) under the ticker symbol "HHC."

Howard Hughes' stock is owned by a number of institutional and retail investors. Top institutional shareholders include Baillie Gifford & Co. (5.74%), Principal Financial Group Inc. (4.55%), Horizon Kinetics Asset Management LLC (1.33%), State Street Corp (1.24%), Donald Smith & CO. Inc. (1.20%) and Russell Investments Group Ltd. (1.11%). Insiders that own company stock include Adam R Flatto, Allen J Model, David Michael Striph, Douglas Johnstone, Greg Fitchitt, James Carman, Jeffrey D Furber, Kevin Orrock, Paul H Layne, Pershing Square Capital Manage, Peter F Riley and Sarah M Vasquez.
View institutional ownership trends.

Shares of HHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of HHC stock can currently be purchased for approximately $58.41.

Howard Hughes (NYSE:HHC) has a market capitalization of $2.92 billion and generates $1.43 billion in revenue each year. The financial services provider earns $56.10 million in net income (profit) each year or $2.62 on an earnings per share basis.

The company employs 530 workers across the globe.

Howard Hughes' mailing address is 13355 Noel Road 22nd Floor, DALLAS TX, 75240. The official website for the company is www.howardhughes.com. The financial services provider can be reached via phone at (281) 719-6100, via email at andrew.davis@howardhughes.com, or via fax at 214-741-3021.